A Vancouver, BC, pilot project called MySafe is testing a vending machine that dispenses safe doses of hydromorphone to individuals with opioid use disorder. Screened and registered opioid addicts who are at high-risk for overdose can access prescription hydromorphone from the MySafe vending machine. Project leader Mark Tyndall, MD, professor of medicine at the University of British Columbia School of Population and Public Health in Vancouver, observes: "I do believe if you allow people to stabilize their drug routine a little bit more by having a secure and safe place where they can get their drugs, then there will be much more time for connection." Described as the "world's first biometric opioid dispensing machine," MySafe scans the vein pattern in users' palms to confirm their identity before dispensing prescribed, appropriate doses of hydromorphone. Participants can use the machine up to 4 times a day. To date, 15 people who are considered to be at very high risk for a fentanyl overdose are registered users of MySafe, and Tyndall hopes to raise that number and add more locations. Ricky Bluthenthal, PhD, a professor at the University of Southern California Keck School of Medicine, Los Angeles, feels this approach could work in the United States. Bluthenthal notes, "Opioid agonist treatments are so harshly regulated that it's really difficult for the people who need them to get these drugs. I'd be in favor of vending machines dispensing buprenorphine."